Samantha Shawn Marsh
Psychiatric/Mental Health · Bradford, RINPI 1053743286
Payments from drug & device makers
Across 1,312 payments — averaging $487.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$451K
- Axsome Therapeutics, Inc.$125K
- Corium, LLC$37K
- Otsuka America Pharmaceutical, Inc.$20K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$5K
- Takeda Pharmaceuticals U.S.A., Inc.$826
- plus $269 from 3 others
What the payments were for
- Consulting fees$74,46812%
- Speaking & faculty fees$459,54972%
- Travel & lodging$82,46513%
- Food & beverage$22,4934%
- Education$910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 865 | $451,417 |
| Axsome Therapeutics, Inc. | 230 | $124,631 |
| Corium, LLC | 119 | $36,675 |
| Otsuka America Pharmaceutical, Inc. | 48 | $20,297 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $4,951 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $826 |
| Lundbeck LLC | 6 | $125 |
| Johnson & Johnson | 1 | $118 |
| Alfasigma USA, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$639,066 in reported general payments places this provider in the 95th percentile of 196 psychiatric/mental health providers in Rhode Island.
See all psychiatric/mental health providers in Rhode Island →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 13 | $6,207 |
| Dextroamphetamine Sulfate | 13 | $1,232 |
| Lamotrigine | 19 | $453 |
| Duloxetine Hcl | 29 | $442 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 13 | $419 |
| Trazodone Hcl | 21 | $398 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 20 | $384 |
| Sertraline Hcl | 15 | $373 |
| Bupropion XlBupropion Hcl | 11 | $301 |
| Quetiapine Fumarate | 16 | $175 |
| Alprazolam | 13 | $125 |
| Lorazepam | 14 | $39 |
| Topiramate | 11 | $6 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $826 | $6,20713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 196 psychiatric/mental health providers in Rhode Island.
Other psychiatric/mental health in Bradford
- Samuel KaufmanRiverside$19K
- Katie ThayerWarwick$16K
- Arielle RoundsWarwick$15K
- Eniayo EgberongbeCranston$12K
- Deborah HorvitzWarwick$10K
- Donna McDonaldProvidence$9K
- Timothy PepinNorth Smithfield$9K
- Anita ObengCranston$8K
- Alyssa KortschinskyWarwick$8K
- Nancy SerabianNorth Providence$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.